Commit To Buy Supernus Pharmaceuticals At $7, Earn 16.4% Annualized Using Options

Investors considering a purchase of Supernus Pharmaceuticals Inc (SUPN) stock, but tentative about paying the going market price of $8.29/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2015 put at the $7 strike, which has a bid at the time of this writing of 55 cents..